BioWorld

April 14, 2008

Pinning High Hopes on Amyloid for Alzheimer

The limited effects of leading treatments for Alzheimer's disease has helped spur a growing field of research into new drug targets that could slow the course of the disease. (BioWorld Financial Watch) Read More

Money Raised By Month

Stock Winners and Losers For The Week

Phase I Clinical Trials Update: March 2008

Phase II Clinical Trials Update: March 2008

Pivotal/Phase III Clinical Trials Update: March 2008

Non-U.S. Clinical Trials And Regulatory Actions: March 2008

FDA Submissions, Approvals And Other Actions: March 2008

BioWorld Stock Report For Public Biotechnology Companies

Today's news in brief

BioWorld

BioWorld briefs for Dec. 24, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 24, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...